P & B Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.50 M
- Company Age 60 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.36 M
- Satisfied Charges ₹ 4.33 Cr
- Revenue Growth -24.68%
- Profit Growth -36.96%
- Ebitda 314.60%
- Net Worth 0.13%
- Total Assets -4.89%
About P & B Laboratories
P & B Laboratories Private Limited (PBLPL) was founded in India on 01 October 1964 and has a glorious history of 60 years and four months.Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as P & B Laboratories Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹9.36 M. The company has closed loans amounting to ₹4.33 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rupa Patel, Sohini Patel, and Hemendra Patel serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110MH1964PTC013023
- Company No.
013023
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 1964
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at P & B Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupa Patel  | Director | 31-Jan-2018 | Current |
| Sohini Patel | Director | 06-Sep-1968 | Current |
| Hemendra Patel | Director | 01-Jun-2007 | Current |
Financial Performance of P & B Laboratories.
P & B Laboratories Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 24.68% decrease. The company also saw a substantial fall in profitability, with a 36.96% decrease in profit. The company's net worth moved up by a moderate rise of 0.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of P & B Laboratories?
In 2021, P & B Laboratories had a promoter holding of 31.50% and a public holding of 68.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
P And B Pharmaceuticals Private LimitedRupa Patel, Sohini Patel and 1 more are mutual person
Charges (Loans)
₹9.36 M
₹43.26 M
Charges Breakdown by Lending Institutions
- Bank Of India : 0.94 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Sep 2020 | Bank Of India | ₹2.36 M | Open |
| 05 May 2008 | Bank Of India | ₹7.00 M | Open |
| 05 May 2008 | Bank Of India | ₹3.73 Cr | Satisfied |
| 06 Dec 2006 | Bank Of India | ₹6.00 M | Satisfied |
How Many Employees Work at P & B Laboratories?
P & B Laboratories has a workforce of 2 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of P & B Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped P & B Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
